Motor neurone disease in South Estonia Diagnosis and incidence rate
1998; Wiley; Volume: 98; Issue: 1 Linguagem: Inglês
10.1111/j.1600-0404.1998.tb07373.x
ISSN1600-0404
AutoresKatrin Gross‐Paju, M. Ööpik, Siiri‐Merike Lüüs, I Kalbe, L. Puksa, Tanel Lepik, Ä. E. Kaasik,
Tópico(s)Muscle Physiology and Disorders
ResumoActa Neurologica ScandinavicaVolume 98, Issue 1 p. 22-28 Motor neurone disease in South Estonia Diagnosis and incidence rate K. Gross-Paju, Corresponding Author K. Gross-Paju Tartu University Hospital, Department of NeurologyL. Puusepa 2, Tartu, EE2400, EstoniaSearch for more papers by this authorM. Ööpik, M. Ööpik Tartu University Hospital, Department of NeurologySearch for more papers by this authorS. M. Lüüs, S. M. Lüüs Tartu University Hospital, Department of NeurologySearch for more papers by this authorI. Kalbe, I. Kalbe Tartu University Hospital, Department of NeurologySearch for more papers by this authorL. Puksa, L. Puksa Tartu University Hospital, Department of NeurologySearch for more papers by this authorT. Lepik, T. Lepik Tartu University Hospital, Department of NeurologySearch for more papers by this authorA. E. Kaasik, A. E. Kaasik Tartu University Hospital, Department of NeurologySearch for more papers by this author K. Gross-Paju, Corresponding Author K. Gross-Paju Tartu University Hospital, Department of NeurologyL. Puusepa 2, Tartu, EE2400, EstoniaSearch for more papers by this authorM. Ööpik, M. Ööpik Tartu University Hospital, Department of NeurologySearch for more papers by this authorS. M. Lüüs, S. M. Lüüs Tartu University Hospital, Department of NeurologySearch for more papers by this authorI. Kalbe, I. Kalbe Tartu University Hospital, Department of NeurologySearch for more papers by this authorL. Puksa, L. Puksa Tartu University Hospital, Department of NeurologySearch for more papers by this authorT. Lepik, T. Lepik Tartu University Hospital, Department of NeurologySearch for more papers by this authorA. E. Kaasik, A. E. Kaasik Tartu University Hospital, Department of NeurologySearch for more papers by this author First published: 29 January 2009 https://doi.org/10.1111/j.1600-0404.1998.tb07373.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract The current study evaluated the diagnostic standards of MND and epidemiological markers of MND in Estonia. A total of 108 patients were referred to the University Hospital from 1986 to 1995 with the first suggested diagnosis or final diagnosis of amyotrophic syndrome, amyotrophic lateral sclerosis (ALS), progressive bulbar paralysis (PBP) or progressive muscular atrophy (PMA). In addition neurologists of the region and the National Society of Neuromuscular disorders were contacted. Some 94 patients satisfied the diagnostic criteria. The annual incidence rate in South Estonia and in the city of Tartu ranged from 0.5 to 2.8 per 100,000. The mean annual incidence rate in Tartu is 1.98 and in South Estonia in general 1.3. The highest incidence rate was 8.3 for men in the age group 60 to 64 years and 7.49 in the age group 70–74; among female patients the highest incidence rate -4.6 was in the age group from 65 to 69. References 1 Chancellor AM, Warlow CP. Adult onset motor neurone disease: world wide mortality incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992: 55: 1106– 15. 2 Sienko DG, Davis JP, Taylor JA, Brooks R. Amyotrophic lateral sclerosis. A case control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990: 47: 38– 41. 3 Gunnarson LG, Lygner PE, Veiga-Cabo J, Pedro-Cuesta J. An epidemic like cluster of motoneurone disease in a Swedish county during a period 1973–1984. Neuroepidemiology 1996: 15: 142– 52. 4 Hondkarian OA, Maksudov GA. About epidemiology amyotrophic lateral sclerosis. Vestnik AMN SSR, Moscow: Medicina 1970, 1: 83– 6 (in Russian). 5 Hondkarian OA, Bunina TL, Zavalishin IA. Amyotrophic lateral sclerosis. Moscow: Medicina, 1978: 9– 10 (in Russian). 6 Alajev BA. Some regional peculiarities of the clinical picture and epidemiology of Amyotrophic lateral sclerosis. Zh Nevropatol Psikhitatr im S S Korsakova, 1980: 11: 1334– 7 (in Russian). 7 Protas II, Drakina SA. Amyotrophic lateral sclerosis in Byelorussia, From Congress neurology and psychiatry. Abstracts, Moscow, Medgiz, 1981: 3: 539– 41 (in Russian). 8 Suhomski BI. Distribution of amyotrophic lateral sclerosis, subacute and chronic poliomyelitis in adults in Rostov region from 1941 to 1970. From Degenerative diseases of the central nervous system. Ufa, 1973: 17– 23 (in Russian). 9 Murros K, Fogelholm R. Amyotrophic lateral sclerosis in middle Finland: an epidemiological study. Acta Neurol Scand 1983: 67: 41– 7. 10 Forsgren L, Almay BGL, Holmgren G, Wall S. Epidemiology of motor neurone disease in northern Sweden. Acta Neurol Scand 1983: 68: 20– 9. 11 Tysnes O-B, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, Western Norway. Acta Neurol Scand 1991: 83: 280– 5. 12 Population age structure. Towns and counties of Estonia. Statistical Office of Estonia, Tallinn, 1995. 13 El Escorial WFN Criteria for ALS Diagnosis. J Neurol Sci 1994: 124 (Suppl): 96– 107. 14 Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925–1977. Neurology 1980: 30: 463– 70. 15 Buckley J, Warlow C, Smith P, Hilton Jones D, Irwine S, Tew JR. Motor neurone disease in England and Wales 1959–1979. J Neurol Neurosurg Psychiatry 1983: 46: 197– 205. 16 Jokelainen M. Amyotrophic lateral sclerosis in Finland. I. An epidemiologic study. Acta Neurol Scand 1977: 56: 185– 93. 17 Hoffman PM, Brody JA. The reliability of death certificate reporting from amyotrophic lateral sclerosis. J Chron Dis 1971: 24: 5– 8. 18 O'Malley F, Dean G, Elian M. Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 1987: 41: 14– 7. 19 Kondo K, Tsubaki T. Changing mortality patterns of motor neurone disease in Japan. J Neurol Sci 1977: 32: 411– 24. 20 Chio A, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health 1992: 46: 517– 18. 21 Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motoneurone disease. Neurology 1986: 36: 511– 17. 22 Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve 1995: 18: 741– 52. 23 Christiansen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 1990: 40: 600– 4. 24 Lilienfield DE, Chan E, Ehland J. et al. Rising mortality from motoneurone disease in the USA, 1964–1984. Lancet 1989: 1 (8640): 710– 13. 25 Lopez-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J. Motoneurone disease in Cantabria. Acta Neurol Scand 1988: 77: 1– 5. 26 Hern JEC, Knight R, Davidson D et al. The Scottish motor neurone disease register: a prospective study of adult onset motor neurone disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992: 55: 536– 41. 27 Dean G, Quigley M. Motor neurone disease in a defined English population: Estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 1994: 57: 450– 4. 28 Mochecka-Thoelke A. Clinical pattern and epidemiological analysis of amyotrophic lateral sclerosis in the Lodz Region in 1980–1986. Neurologia i Neurochirurgia Polska 1994 28 (2): 189– 94. 29 Eisen A, Schulzer M, Macneil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993: 16: 27– 32. 30 de Domenico P, Malara CE, Marabello L et al. Amyotrophic lateral sclerosis: an epidemiological study in the province of Messina, Italy, 1976–1985. Neuroepidemiology 1988: 7 152– 8. 31 Huber S, Henn V. Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zürich. Schweiz Arch Neurol Psychiatr 1995: 146: 52– 4. Citing Literature Volume98, Issue1July 1998Pages 22-28 ReferencesRelatedInformation
Referência(s)